520 related articles for article (PubMed ID: 25155144)
1. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
2. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
Liang R; Kagwiria R; Zehender A; Dees C; Bergmann C; Ramming A; Krasowska D; Michalska-Jakubus M; Kreuter A; Kraner ME; Schett G; Distler JHW
Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
4. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
[TBL] [Abstract][Full Text] [Related]
5. PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis.
Zhang Y; Shen L; Zhu H; Dreissigacker K; Distler D; Zhou X; Györfi AH; Bergmann C; Meng X; Dees C; Trinh-Minh T; Ludolph I; Horch R; Ramming A; Schett G; Distler JHW
Ann Rheum Dis; 2020 Sep; 79(9):1227-1233. PubMed ID: 32482644
[TBL] [Abstract][Full Text] [Related]
6. Impaired Mitochondrial Transcription Factor A Expression Promotes Mitochondrial Damage to Drive Fibroblast Activation and Fibrosis in Systemic Sclerosis.
Zhou X; Trinh-Minh T; Tran-Manh C; Gießl A; Bergmann C; Györfi AH; Schett G; Distler JHW
Arthritis Rheumatol; 2022 May; 74(5):871-881. PubMed ID: 34807516
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis.
Yamamoto A; Saito T; Hosoya T; Kawahata K; Asano Y; Sato S; Mizoguchi F; Yasuda S; Kohsaka H
Arthritis Rheumatol; 2022 May; 74(5):860-870. PubMed ID: 34882985
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
9. Estrogens Counteract the Profibrotic Effects of TGF-β and their Inhibition Exacerbates Experimental Dermal Fibrosis.
Avouac J; Pezet S; Gonzalez V; Baudoin L; Cauvet A; Ruiz B; Boleto G; Brandely ML; Elmerich M; Allanore Y
J Invest Dermatol; 2020 Mar; 140(3):593-601.e7. PubMed ID: 31476316
[TBL] [Abstract][Full Text] [Related]
10. TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
Laurent P; Allard B; Manicki P; Jolivel V; Levionnois E; Jeljeli M; Henrot P; Izotte J; Leleu D; Groppi A; Seneschal J; Constans J; Chizzolini C; Richez C; Duffau P; Lazaro E; Forcade E; Schaeverbeke T; Pradeu T; Batteux F; Blanco P; Contin-Bordes C; Truchetet ME
Ann Rheum Dis; 2021 Dec; 80(12):1594-1603. PubMed ID: 34285051
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
12. Progranulin Promotes Bleomycin-Induced Skin Sclerosis by Enhancing Transforming Growth Factor-β/Smad3 Signaling through Up-Regulation of Transforming Growth Factor-β Type I Receptor.
Yang T; Zhang X; Chen A; Xiao Y; Sun S; Yan J; Cao Y; Chen J; Li F; Zhang Q; Huang K
Am J Pathol; 2019 Aug; 189(8):1582-1593. PubMed ID: 31108104
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.
Wei J; Fang F; Lam AP; Sargent JL; Hamburg E; Hinchcliff ME; Gottardi CJ; Atit R; Whitfield ML; Varga J
Arthritis Rheum; 2012 Aug; 64(8):2734-45. PubMed ID: 22328118
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
Yokoyama Y; Sekiguchi A; Fujiwara C; Uchiyama A; Uehara A; Ogino S; Torii R; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2018 Oct; 70(10):1661-1672. PubMed ID: 29676521
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis.
Liang M; Dickel N; Györfi AH; SafakTümerdem B; Li YN; Rigau AR; Liang C; Hong X; Shen L; Matei AE; Trinh-Minh T; Tran-Manh C; Zhou X; Zehender A; Kreuter A; Zou H; Schett G; Kunz M; Distler JHW
Sci Transl Med; 2024 Mar; 16(740):eadd6570. PubMed ID: 38536934
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target.
Shi Y; Tang B; Yu J; Luo Y; Xiao Y; Pi Z; Tang R; Wang Y; Kanekura T; Zeng Z; Xiao R
Int Immunopharmacol; 2020 Nov; 88():106886. PubMed ID: 32799115
[TBL] [Abstract][Full Text] [Related]
18. TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy.
Zehender A; Li YN; Lin NY; Stefanica A; Nüchel J; Chen CW; Hsu HH; Zhu H; Ding X; Huang J; Shen L; Györfi AH; Soare A; Rauber S; Bergmann C; Ramming A; Plomann M; Eckes B; Schett G; Distler JHW
Nat Commun; 2021 Jul; 12(1):4404. PubMed ID: 34285225
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX
Luong VH; Utsunomiya A; Chino T; Doanh LH; Matsushita T; Obara T; Kuboi Y; Ishii N; Machinaga A; Ogasawara H; Ikeda W; Kawano T; Imai T; Oyama N; Hasegawa M
Arthritis Rheumatol; 2019 Nov; 71(11):1923-1934. PubMed ID: 31173491
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
Jiang Y; Hu F; Li M; Li Q
Clin Exp Pharmacol Physiol; 2024 Feb; 51(2):e13834. PubMed ID: 38037494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
